Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a US-based immunology company, announced on Monday that it has named Anne Altmeyer, PhD, MBA, MPH as its new director.
Presently, Dr Altmeyer is the president and CEO of TigaTx, Inc. She has earlier served as the chief business officer for Sigilon Therapeutics and Adicet Bio. She has also served in roles of increasing responsibility in corporate development and program management for more than 15 years across large pharmaceutical organisations. Dr Altmeyer has previously held the position of vice president in Global Business Development at Baxalta and vice president in Oncology Business Development and Companion Diagnostics at Novartis. She started her industry career in program management roles at Merck & Company.
Dr Altmeyer holds PhD from the University Louis Pasteur, Strasbourg, France, postdoctoral fellowships at New York University and Cornell University Medical College in New York City, MBA from Rutgers University and a Masters in Public Health from the Robert Wood Johnson Medical School, in New Jersey.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer